Obve\u0161\u010damo vas, da je Ministrstvo za znanost in tehnologijo (MOST) LR Kitajske odprlo \u010detrti razpis za mednarodne projektne predloge na temo COVID-19. Gre za prvi razpis, kjer je dovoljeno in obvezno sodelovanje entitet izven Kitajske. Tuji prijavitelji kljub temu ne bodo financirani s strani MOST, temve\u010d morajo zagotoviti lastna sredstva za sodelovanje v projektu, z izjemo nakupa nekatere opreme, ki ni dostopna na Kitajskem. V tem primeru lahko stro\u0161ke nakupa opreme povrne MOST.<\/p>\n
Rok za spletno prijavo: 8. 7. – 31. 8. 2020<\/u><\/strong> <\/span><\/p>\n Besedilo razpisa (v kitajskem jeziku in neuradni prevod v angle\u0161kem jeziku) se nahaja v priponki.<\/p>\n Nekateri klju\u010dni vidiki razpisa:<\/p>\n – \u00a0 \u00a0 \u00a0 \u00a0 Research that concern human bodies should pass ethics reviews and sign informed consent letter according to relevant rules. Collection, storage, utilisation and provisions of human genetic resources should be carried out in compliance with relevant regulations of the Administration Rules of Human Genetic Resources. Transportation, mail or carrying human genetic resources out of China should be reported and approved in line with relevant rules set out in the Administrative Rules of Human Genetic Resources. Experimental animals and animal tests should observe the national laws, regulations, technical standards and rules on laboratory animal by using up-to-standard experimental animals to conduct animal tests in up-to-standard devices, to ensure that the experiment process is legal, the test results are authentic and effective, and pass the experimental animal welfare and ethic reviews. Relevant research activities should comply with relevant biosafety regulations of the Regulations on the Biosecurity Management of Pathogenic Microbiology Laboratory and the Biosafety Guideline for COVID-19 labs. \u00a0 – \u00a0 \u00a0 \u00a0 \u00a0 \u00a0The content and method of project cooperation shall comply with the relevant laws and regulations of China and the countries (regions, international organizations) where the cooperation institutions are located. Those who conduct clinical research on drugs and vaccines abroad should obtain clinical approvals from the local drug regulatory authorities, and fully understand the specific provisions of relevant local laws and regulations and ethical review requirements, as well as relevant items on medical behaviours and commercial insurance, to avoid violating local laws or causing disputes. \u00a0 – \u00a0 \u00a0 \u00a0 \u00a0 \u00a0The scientific data generated by the projects should be submitted unconditionally and timely to the platform designated by MOST, and be open to all scientists and the general public. \u00a0 – \u00a0 \u00a0 \u00a0 \u00a0 \u00a0The cooperation parties should have a clear agreement or intentional agreement on future attribution of intellectual property rights and the attribution of achievement conversion benefits, and should be in compliance with the relevant provisions of China\u2019s laws and regulations on the attribution of intellectual property rights and the achievement of conversion benefits (IPR agreements or intentional agreements, MOUs, proof letters or relevant articles defining IPRs in cooperation agreements should be annexed). Application Guide international cooperation research on COVID-19 (CN)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Obve\u0161\u010damo vas, da je Ministrstvo za znanost in tehnologijo (MOST) LR Kitajske odprlo \u010detrti razpis za mednarodne projektne predloge na temo COVID-19. Gre za prvi razpis, kjer je dovoljeno in obvezno sodelovanje entitet izven Kitajske. Tuji prijavitelji kljub temu ne bodo financirani s strani MOST, temve\u010d morajo zagotoviti lastna sredstva za sodelovanje v projektu, z … Read more<\/a>","protected":false},"author":201,"featured_media":0,"template":"","categories":[390],"acf":[],"yoast_head":"\n\n\n\n\n\n\n\n\n\n\n\t\n\n
\nApplication Guide international cooperation research on COVID-19 – unofficial translation<\/a><\/p>\n